Ambrilia Biopharma Inc., a biopharmaceutical company developing innovative therapeutics in the fields of cancer and infectious diseases, announced today its second quarter 2006 results and provided an update on lead development programs.
Ambrilia Biopharma Inc., a biopharmaceutical company developing innovative therapeutics in the fields of cancer and infectious diseases, announced today its second quarter 2006 results and provided an update on lead development programs.
